These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 18006764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA.
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP, Huang LC, Ting WC, Chen LM, Chang TY, Lu TL, Lan YH, Liu CC, Yang WH, Lee HZ, Hsieh CJ, Bao BY.
    Cancer Epidemiol Biomarkers Prev; 2009 Nov 15; 18(11):3068-74. PubMed ID: 19900942
    [Abstract] [Full Text] [Related]

  • 6. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D.
    Clin Cancer Res; 2005 Dec 01; 11(23):8321-5. PubMed ID: 16322291
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH, Hua D, Du X.
    Cancer Chemother Pharmacol; 2009 Oct 01; 64(5):1001-7. PubMed ID: 19247656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.
    Freedland SJ, Partin AW, Epstein JI, Walsh PC.
    Cancer; 2004 Apr 15; 100(8):1646-9. PubMed ID: 15073852
    [Abstract] [Full Text] [Related]

  • 10. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug 15; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
    Quinn DI, Henshall SM, Head DR, Golovsky D, Wilson JD, Brenner PC, Turner JJ, Delprado W, Finlayson JF, Stricker PD, Grygiel JJ, Sutherland RL.
    Cancer Res; 2000 Mar 15; 60(6):1585-94. PubMed ID: 10749127
    [Abstract] [Full Text] [Related]

  • 13. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul 15; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
    Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Eaton A, Mohrenweiser HW, Newman B, Bell DA.
    Cancer Epidemiol Biomarkers Prev; 2001 Mar 15; 10(3):217-22. PubMed ID: 11303590
    [Abstract] [Full Text] [Related]

  • 15. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM, Koch MO, Eble JN, Lin H, Cheng L.
    J Urol; 2006 May 15; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [Abstract] [Full Text] [Related]

  • 16. Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy.
    Bauer JJ, Connelly RR, Sesterhenn IA, Bettencourt MC, McLeod DG, Srivastava S, Moul JW.
    Cancer; 1997 Mar 01; 79(5):952-62. PubMed ID: 9041158
    [Abstract] [Full Text] [Related]

  • 17. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [Abstract] [Full Text] [Related]

  • 18. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN, Roemeling S, Kranse R, Schröder FH, van der Kwast TH.
    Eur Urol; 2007 Apr 01; 51(4):931-9. PubMed ID: 16935413
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.